This project aims to develop an innovative approach to integrating modern electronics and AI with healthcare through the development of AI-driven flexible bioelectronics therapeutics. The project addresses the mismatch between traditional rigid electronics and the soft, dynamic nature of the human body, which has limited the seamless integration of high-performance sensors, stimulators, and computational units with the human body. Our solution involves the convergence of flexible nanoelectronics, advanced surgical techniques, and sophisticated AI agents to create bioelectronic interfaces that can be precisely deployed within the body. These interfaces are designed for long-term stability and high-resolution recording and control, targeting specific organs with cellular precision. The AI agent decodes signals from the body to provide personalized, patient-specific treatments, aiming to revolutionize the diagnosis and management of complex diseases such as neurological disorders, cancers, and diabetes. This platform aims to redefine the future therapeutic paradigms, promising significant advancements in medical technology and healthcare delivery.